Efficacy and safety of direct-acting antiviral therapy for chronic hepatitis C genotype 6: A meta-analysis

BACKGROUND: Because of the heterogeneity of hepatitis C virus (HCV) distribution of different genotypes, large-scale clinical trials on direct-acting antiviral (DAA) mainly included patients with genotype 1 and genotype 3 infection. Data on the efficacy of direct-acting antiviral agents in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Aoran, Xu, Pan, Wang, Jin, Li, Zuli, Wang, Shunli, Jiang, Xiaoyan, Ren, Hong, Luo, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531202/
https://www.ncbi.nlm.nih.gov/pubmed/31096473
http://dx.doi.org/10.1097/MD.0000000000015626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531202/
https://www.ncbi.nlm.nih.gov/pubmed/31096473
http://dx.doi.org/10.1097/MD.0000000000015626

Ejemplares similares